Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genemed Biotechnologies is a private U.S. life science and diagnostics company focused on surgical pathology, personalized medicine, and molecular diagnostic laboratory support. The company markets tissue-based diagnostics products including immunohistochemistry (IHC) reagents, chromogenic and fluorescent in situ hybridization (CISH/FISH) probes, and recombinant proteins, and it also provides molecular diagnostics services. In addition to selling its own reagent lines, Genemed offers contract development and manufacturing services for pharmaceutical and diagnostic customers, including PCR control and component manufacturing, IHC/ISH development and manufacturing, and recombinant protein production. Its business appears oriented toward commercial diagnostic tools and laboratory solutions rather than a traditional therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genomed Biotechnologies.